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Abstract: Although granulocytes are the most abundant leukocytes in human blood, their involvement
in the immune response against cancer is not well understood. While granulocytes are known for
their “oxidative burst” when challenged with tumor cells, it is less known that oxygen-dependent
killing of tumor cells by granulocytes includes peroxidation of lipids in tumor cell membranes,
yielding formation of reactive aldehydes like 4-hydroxynonenal (4-HNE) and acrolein. In the present
work, we investigate the role of reactive aldehydes on cellular redox homeostasis and surface toll-like
receptor 4 (TLR4) expression. We have further study the granulocyte-tumor cell intercellular redox
signaling pathways. The data obtained show that granulocytes in the presence of 4-HNE and acrolein
induce excessive ROS formation in tumor cells. Acrolein was also shown to induce granulocyte TLR4
expression. Furthermore, granulocyte-mediated antitumor effects were shown to be mediated via
HOCl intracellular pathway by the action of NADPH oxidase. However, further studies are needed
to understand interaction between TLR4 and granulocyte-tumor cell intercellular signaling pathways.
Keywords: reactive oxygen species (ROS); oxidative stress; lipid peroxidation; acrolein;
4-hydroxynonenal (4-HNE); oxidative burst; granulocytes; cancer cells; growth control;
cancer regression
1. Introduction
Granulocytes are the most abundant leukocytes in the human body, which provide the first line of
defense against pathogens and play a fundamental role in the innate immune response [1]. Although
granulocytes are closely associated with tumor cells, their exact role within tumor microenvironment
remains controversial [2–4]. Activated granulocytes generate vast amounts of reactive oxygen species
(ROS) that were shown to be crucial for the oxygen-dependent killing of tumor cells [5,6]. ROS
generation by activated granulocytes involves various mechanisms, among which NADPH oxidase
seems to be the key source of granulocyte derived ROS during the oxidative burst [7,8]. Activation of
NADPH oxidase was shown to be toll-like receptor 4 (TLR4)-dependent in response to hemorrhagic
shock or pathogens [9,10]. Over a decade ago it was suggested that a tumor cell-induced oxidative
burst of granulocytes could also be via activation of toll-like receptors (TLR) [5], however this still
remains to be elucidated.
Depending on the amount of ROS and their distance from the target cells, ROS can mediate
cellular responses or cause oxidative damage to macromolecules [3,11,12]. Bauer has earlier described
four ROS intercellular signaling pathways, among which the induction of apoptosis of transformed
cells was mainly via HOCl intercellular signaling pathways [13]. In granulocyte-mediated tumor cell
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destruction, this pathway would depend on the superoxide anion (•O2−) derived from both sides.
The granulocyte NADPH oxidase generates •O2− that further dismutase to hydrogen peroxide (H2O2).
The H2O2 is then converted into HOCl by the action of myeloperoxidase (MPO). HOCl can also
react with •O2−, yielding highly reactive hydroxyl radical (OH•), that is able to directly induce lipid
peroxidation (LPO) [3].
Peroxidation of polyunsaturated fatty acids (PUFAs) that are esterified in membranes can yield
reactive aldehydes, such are acrolein and 4-hydroxynonenal (4-HNE). High amounts of reactive
aldehydes are cytotoxic. However, in small amounts they have important cell signaling roles of
regulating cell proliferation, differentiation, and apoptosis. Reactive aldehydes are longer living
molecules, compared to ROS, that alter different signaling pathways either directly or indirectly by
covalent modification of macromolecules [14–16]. Reactive aldehydes can also be generated by activated
granulocytes that employ an MPO hydrogen peroxide chloride system that can convert L-threonine
into 2-hydroxypropanal, an acrolein precursor, and acrolein [17]. Although the involvement of reactive
aldehydes in tumor development has been intensively studied for decades, the exact mechanisms of
their concentration dependents and cell type specific effects on the tumor–host relationship need to be
further elucidated [18–23].
Therefore, in the present work we investigate the involvement of two particular reactive aldehydes,
acrolein, being the most reactive, and 4-HNE, a major biomarker of lipid peroxidation also denoted
as “second messenger of free radicals”, on the respiratory burst of granulocytes, as well as the
granulocyte-cancer cell intercellular signaling, in order to reveal the critical steps responsible for
granulocyte-mediated destruction of cancer cells.
2. Materials and Methods
2.1. Animals
Experiments were performed on three-month-old male Sprague Dawley rats. Water and food
were given ad libitum. All the experiments were performed in accordance with the ILAR Guide for the
Care and Use of Laboratory Animals, EU Council Directive (86/609/EEC) and the Croatian Animal
Protection Act (Official Gazette 135/06). Ethical approval obtained from the RBI and MSES for the
grant MSES 098-0982464-2519.
2.2. Treatment of Animals and Isolation of Granulocytes
As a source for granulocytes, 4 healthy control rats were used. Rats were s.c. injected with
5 mL Sephadex on each side, in the lower dorsal quadrant, and 24 h later the Sephadex papules were
surgically removed and the granulocytes were isolated, as described before [5]. The granulocyte cell
suspension was counted and diluted in a RPMI 1640 medium to the desired concentration, while their
viability, checked by the trypan blue exclusion test, was found to be 97%.
2.3. Tumor Cell Lines
Three rat derived cell lines, C6 glioma, Walker W256 carcinoma, and PC12 rat adrenal
pheochromocytoma, (ATCC, CCL-107, CCL-38, CRL-1721) were used. The cells were adapted
to grow as monolayers cultured at 37 ◦C in a RPMI 1640 medium, supplemented with 5% (W256 and
PC12) or 10% (C6) fetal bovine serum (FBS) and 1% Penicillin/Streptomycin in a humidified atmosphere.
2.4. 4-HNE and Acrolein
The aldehyde, in the form of 4-hydroxy-2-nonenal-dimethylacetal (HNE-DMA), was kindly
provided by the Institute of Molecular Biology, Biochemistry and Microbiology, Graz, Austria. Prior to
the experiment, it was activated with 1 mM HCl (Kemika, Zagreb, Croatia) for 2 h. The concentration
of HNE was determined by spectrophotometry (UV-1601 spectrophotometer; Shimadzu, Tokyo,
Japan) [24].
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Prior to treatment, cells were left in a serum free medium for 1 h. HNE and acrolein were freshly
prepared before each experiment and used in a concentration of 12.5 µM in a RPMI medium (2% FCS).
2.5. Investigating the Ability of 4-HNE and Acrolein to Modulate Granulocyte and Tumor Cells
Redox Homeostasis
Intracellular ROS production was examined in granulocytes and tumor cells using a redox
sensitive probe 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA; Fluka, Steinheim, Germany),
as described before [25,26]. Briefly, the tested cells (granulocytes or tumor cells) were treated with
10 µM DCFH-DA in Hanks’ Balanced Salt Solution (HBSS) in 5% CO2/95% air at 37 ◦C for 30 min.
Afterwards the DCFH loaded cells were either co-cultured with the other type of cells (tumor cells
or granulocytes, respectively) or left alone as control. The seeding density of the granulocytes and
tumor cells, cultured in 96-well microcytoplates, was 2 × 105 and 2 × 104 cells per culture, respectively.
The mixed cultures were then washed and incubated with an HBSS buffer, supplemented with 12.5 µM
HNE, 12.5 µM acrolein, or left untreated as control. After 2 h, the fluorescence intensity was measured
with a Variant fluorescence spectrophotometer with an excitation wavelength of 500 nm and emission
detection at 529 nm. The arbitrary units, relative fluorescence units (RFU), were based directly on
fluorescence intensity.
2.6. Determination of Surface TLR4 Expression by Flow Cytometry
Influence of reactive aldehydes on the TLR4 expression was measured in granulocytes and W256
tumor cells. The seeding density of granulocytes, cultured in 24-well plates, was 106 cells per culture
in the RPMI 1640 medium. The seeding density of the tumor cells was 2 × 105 cells per culture,
irrespective if cultured alone or if added to the granulocytes. The cell cultures were incubated for 2 h
in the RPMI 1640 medium, supplemented with 12.5 µM HNE, 12.5 µM acrolein, or left untreated as
control, at 37 ◦C in a humidified air atmosphere with 5% CO2. Cells were then washed with PBS and
incubated with an anti-TLR4 antibody (Abcam, Cambridge, UK) or an isotype control (Abcam, UK) for
60 min, followed by the incubation with an AlexaFluor 488 conjugated secondary antibody (Invitrogen,
Carlsbad, CA, USA) for 60 min on ice. The stained cells were then analyzed with FACSCalibur™
(Becton Dickinson, San Jose, CA, USA). The results were analyzed with WinMDI v2.9 software (Joseph
Trotter, San Diego, CA, USA).
2.7. The Effect of Granulocyte Intercellular HOCl Signaling on the Tumor Cell Proliferation
Granulocytes were co-cultured with tumor cells at a ratio of 10:1 in 96-well plates and the
proliferation of C6 and PC12 tumor cells was measured by the 3H-thymidine (3H-TdR) incorporation
assay, similarly to as described before [27]. The effects of HOCl intercellular redox signaling on tumor
cell proliferation were investigated using the NADPH oxidase inhibitor apocynin (APO, 50 µg/mL,
Sigma, Steinheim, Germany), the peroxidase inhibitor 4-aminobenzoyl hydrazide (ABH, 25 µM, Acros
Organics, Geel, Belgium), the HOCl scavenger taurine (Tau, 25 mM, Sigma), the hydroxyl radical
scavenger mannitol (Man, 10 mM, Kemika, Zagreb, Croatia), or the singlet oxygen scavenger histidine
(2 mM, Sigma). Briefly, tumor cells alone or co-cultured with granulocytes were exposed to different
inhibitors and incubated for 24 h at 37 ◦C in a humidified air atmosphere with 5% CO2. After 24 h,
radioactive 3H-TdR was added to each culture and left for additional 48 h. The incorporation of 3H-TdR
was measured by a β-liquid-scintillation counter (LS 3800 Series; Beckman, Indianapolis, IN, USA).
2.8. Statistics
Descriptive statistics were shown as the mean ± SD. The significance of differences between
groups was assessed using the Student t-test and the Chi-square test. When more than two groups
were compared, we used one sided ANOVA with appropriate post hoc testing. The IBM SPSS Statistics
v21 (IBM Corp., New York, NY, USA) software for Microsoft Windows were used. Differences with p
less than 0.05 were considered as statistically significant.
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3. Results
Intracellular ROS production in granulocytes and W256 tumor cells is presented in Figure 1.
Exposure of granulocytes to reactive aldehydes 4-HNE and acrolein did not stimulate granulocyte
intracellular ROS production, while acrolein itself even reduced granulocyte intracellular ROS
production when compared to untreated granulocytes (p < 0.05). However, in the presence of
W256 tumor cells, granulocytes showed a significant increase of the intracellular ROS production.
Such increment of the oxidative burst of granulocytes was further enhanced in the presence of acrolein
(Figure 1A, p < 0.05), but not in the presence of 4-HNE (Figure 1A, p > 0.05). Granulocytes themselves
did not influence intracellular ROS production in W256 cancer cells (Figure 1B, p > 0.05), while the
addition of both reactive aldehydes caused a significant increase of intracellular ROS production by
cancer cells (Figure 1B, p < 0.05, for both 4-HNE and acrolein).
Figure 1. Intracellular ROS production in granulocytes (A) and in W256 tumor cells (B). Mean values ±
SD are given, (*) significance p < 0.05 compared to untreated granulocytes, (**) significance p < 0.01
compared to co-culture of granulocytes and W256 tumor cells and (***) significance p < 0.05 compared
to co-culture of granulocytes and W256 tumor cells.
The impact of 4-HNE and acrolein on the TLR4 surface expression of granulocytes and of W256
cancer cells is shown in Figure 2. Although 4-HNE did not show any particular effect on the TLR4
expression, a significant shift was observed when granulocytes were exposed to acrolein, regardless of
the presence of tumor cells (Figure 2).
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Figure 2. Representative flow cytometry histograms showing TLR4 surface expression on granulocytes
and W256 tumor cells. Granulocytes and tumor cells were stained with antibodies specific for TLR4
(open histogram) or their isotype control (gray histogram).
Since the anticancer effects of granulocytes were already well studied on W256 cancer cells,
the effect of granulocytes on the proliferation of the other murine cancer cells, notably on PC12
pheochromocytoma and C6 glioma, were studied for the first time, as is shown in Figure 3. Granulocytes
inhibited the proliferation by 40% and 55% for C6 and for PC12 tumor cells, respectively. In order to
understand the impact of specific granulocyte derived ROS and the importance of intercellular redox
signaling, the specific parts of intercellular HOCl signaling pathway were inhibited by the addition of
respective inhibitors. Treatment of tumor cells with mannitol, histidine, taurine, and ABH did not
have effect on C6 cell proliferation, while it reduced proliferation of PC12 cells. However, treatment of
both C6 and PC12 cells with APO inhibited tumor cell proliferation compared to untreated tumor cells
with the value p < 0.05. Furthermore, while the addition of mannitol, histidine, taurine, and ABH to
the co-culture of granulocytes and tumor cells did not show any effect on the tumor cell proliferation,
compared to untreated co-cultures (p > 0.05 for both cell lines), the addition of APO, which specifically
inhibits the NADPH oxidase, abolished the anti-tumor effect of granulocytes (p < 0.05 for both C6
and PC12).
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Figure 3. Granulocyte HOCl intercellular redox signaling inhibits tumor cell proliferation. C6 (A) or
PC12 (B) tumor cells treated with granulocytes in the presence or absence of inhibitors (Man—hydroxyl
radical scavenger; Tau—HOCl scavenger; His—singlet oxygen scavenger; APO—NADPH oxidase
inhibitor; ABH—peroxidase inhibitor). Mean values ± SD are given, (*) significance p < 0.01, compared
to untreated tumor cells, (**) significance p < 0.01 compared to co-culture of granulocytes and tumor
cells, and p > 0.01 compared to tumor cells alone.
4. Discussion
The role of granulocytes in the host’s defense against cancer is not well understood, although
the important role of granulocyte-derived ROS in the oxygen-dependent killing of tumor cells was
recognized more than 30 years ago [28]. In the meantime, dual roles of granulocytes, both in tumor
progression [5,6] and tumor regression [4,26,29], were documented. Since it is known that ROS generated
by an oxidative burst of granulocytes can lead to production of reactive aldehydes acting as “second
messengers of free radicals”, we hypothesize that reactive aldehydes in the presence of granulocytes
might be the crucial factors determining the fate of cancer cells. In favor to our hypothesis are not
only results of the current study, but also earlier studies, especially on human colon carcinoma [30].
Namely, production of 4-HNE by inflammatory and stromal cells increased autocrine/paracrine
suppression of colon epithelial cells through TGF-β1 and c-Jun N-terminal kinase upregulation [31].
Complementary to that, acrolein was found to be associated with colon tumorigenesis, too. Namely, in
cases of adenomas, the amount of acrolein was increased from a moderate appearance in tubular and
villotubular low-grade adenomas to abundant and diffusive distribution in high-grade villotubular
adenomas and Dukes A carcinomas. However, in advanced Dukes B and C carcinomas, acrolein was
hardly noticed, while, opposite to cancer tissue, acrolein was abundant in non-malignant colon tissue
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adjacent to the cancer [32]. Though, it was initially assumed that such changes in reactive aldehydes, in
particular of acrolein which is not usually present in human tissue under physiological circumstances,
might reflect negative consequences of the food-derived LPO. Recent findings on human liver and
primary, as well as metastatic, lung cancer suggest that reactive aldehydes might actually represent an
important mechanism of host defense against cancer invasion [33,34]. Moreover, direct involvement of
4-HNE and acrolein was reported for granulocyte-mediated W256 regression. So, we may assume that,
in addition to cases of human cancer, granulocytes might be the source of reactive aldehydes in the
vicinity of cancer [28]. As the acrolein formation was observed in an early stage of W256 regression, we
have proposed that acrolein might serve as a mediator of positive feedback to promote myeloperoxidase
activity and further induce ROS production, eventually generating 4-HNE [29]. In the present work
we show for the first time that reactive aldehydes, in the tested concentrations, did not solely affect
in vitro cellular redox homeostasis, either of tumor cells or granulocytes. However, because acrolein
enhanced the oxidative burst of granulocytes in the presence of W256 cells and vice versa, our current
findings are in line with our earlier hypothesis. Although 4-HNE had similar effects in our study, the
fact that it was less potent than acrolein might reflect differences in their biochemical reactivity and/or
its recently reported inhibitory effect on the granulocyte activation and phagocytosis [35].
The most important role of reactive aldehydes might be in the disturbance of tumor cell redox
homeostasis, as indicated in the current study, showing that only granulocytes in the presence of
reactive aldehydes have the ability to significantly affect the redox balance of tumor cells. Namely,
acrolein was shown to upregulate granulocyte surface TLR4 expression. However, whether the increase
in TLR4 abundance on the membranes is the result of a shuttling of the protein or is an induction of the
overall protein, still remains to be elucidated. Increased membrane expression of granulocyte TLR4
could impact specific signaling pathways, like NF-kappa B and STAT3, and could mediate molecular
mechanisms to promote NADPH oxidase activation and, consequently, ROS production and growth
suppression/decay of tumor cells [36]. Indeed, the granulocyte mediated antitumor effect was inhibited
by APO, an NADPH oxidase inhibitor, but not by Man (a hydroxyl radical scavenger), Tau (a HOCl
scavenger), His (a singlet oxygen scavenger), or ABH (peroxidase inhibitor). We have also observed
that, despite the fact that APO blocked the anti-cancer effect of granulocytes, without the presence
of granulocyte, APO was able to inhibit tumor cell proliferation. The inhibitory effect of APO has
already been described earlier on both human and rat prostate cancer cell lines by inducing the cell
cycle arrest [37,38]. In LNCaP prostate cancer cells, APO had an anti-proliferative effect only when
added at higher concentrations, while it did not have effects at lower concentrations [38]. The above
could explain the effects observed in this study, where addition of granulocytes increased the APO
targets and decreased the chance of the inhibitor to exhibit its effects on tumor cells. Hence, our
results indicate that granulocyte mediated malignant destruction is dependent on HOCl intercellular
signaling pathways by the action of the NADPH oxidase. Similarly, recent study also highlighted the
importance of the HOCl signaling pathway as the pathway that might prevent tumorigenesis in the
lactobacillus/peroxidase system mediated antitumor effect [39].
The results of our study suggest two possible mechanisms of involvement of reactive aldehydes
in the anti-cancer effects of granulocytes, as follows:
1. Reactive aldehydes, by impairing the membrane integrity, enable ROS to enter the tumor cells or
2. coordinated action of granulocyte derived ROS and reactive aldehydes can induce excessive
intracellular ROS production, thus causing decay of cancer cells.
In conclusion, reactive aldehydes, formed as a consequence of an intense oxidative burst
of granulocytes, might mediate antitumor effects of granulocytes by impairing tumor cell redox
homeostasis and, also, at least in the case of acrolein, induce granulocyte TLR4 expression. The link
between TLR4 expression and NADPH oxidase stimulated ROS generation is well known and might
explain the granulocyte-mediated antitumor effects through the HOCl intracellular pathway by the
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action of the NADPH oxidase, which could eventually determine the tumor–host relationship in a
desirable way for cancer regression.
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